Relaxation of subarachnoid hemorrhage-induced spasm of rabbit basilar artery by the K+ channel activator cromakalim

Stroke

Volumn 27, Issue 2, 1996, Pages 311-316

  Zuccarello, Mario ^a,b   Bonasso, Christian L ^a   Lewis, Adam I ^a   Sperelakis, Nicholas ^a   Rapoport, Robert M ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

basilar artery; cerebral arteries; potassium channels; rabbits; vasodilatation; vasospasm

Indexed keywords

ADENYLATE CYCLASE ACTIVATOR; CROMAKALIM; FORSKOLIN; GLIBENCLAMIDE; GUANYLATE CYCLASE ACTIVATOR; NITROPRUSSIDE SODIUM; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL STIMULATING AGENT; POTASSIUM CHLORIDE; PROTEIN KINASE C INHIBITOR; SEROTONIN; STAUROSPORINE; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; BASILAR ARTERY; BRAIN VASOSPASM; CELL MEMBRANE POTENTIAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE FIBER; SUBARACHNOID HEMORRHAGE;

EID: 0030021276     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.2.311     Document Type: Article

References (37)

1. Bevan JA, Bevan RD. Arterial wall changes in chronic cerebrovasospasm: in vitro and in vivo pharmacological evidence. Annu Rev Pharmacol Toxicol. 1988;28:311-329.
2. Findlay JM, Macdonald RL, Weir BKA. Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Cerebrovasc Brain Metab Rev. 1991;3:336-361.
3. Dorsch NWC. A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage, part III: mechanisms of action of calcium antagonists. J Clin Neurosci. 1994;1:151-160.
4. Frazee JG, Giannotta SL, Stern WE. Intravenous nitroglycerine for the treatment of chronic cerebral vasoconstriction in the primate. J Neurosurg. 1981;55:865-868.
5. Varsos VG, Liszczak TM, Han DH, Kistler JP, Vielma J. Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a 'two-hemorrhage' canine model. J Neurosurg. 1983;58:11-17.
6. Espinosa F, Weir B, Overton T, Castor W, Grace M, Boisvert D. A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. J Neurosurg. 1984;60:1167-1175.
7. Krueger C, Weir B, Nosko M, Cook D, Norris S. Nimodipine and chronic vasospasm in monkeys, part II: pharmacological studies of vessels in spasm. Neurosurgery. 1985;16:137-140.
8. Nosko M, Weir B, Krueger C, Cook D, Norris S, Overton T, Boisvert D. Nimodipine and chronic vasospasm in monkeys, part I: clinical and radiological findings. Neurosurgery. 1985;16:129-136.
9. Lewis RP, Weir BKA, Nosko MG, Tanabe T, Grace MG. Intrathecal nimodipine therapy in a primate model of chronic cerebral vasospasm. Neurosurgery. 1988;22:492-500.
10. Vorkapic P, Bevan RD, Bevan JA. Longitudinal time course of reversible and irreversible components of chronic cerebrovasospasm of the rabbit basilar artery. J Neurosurg. 1991;74:951-955.
11. Matsui T, Kaizu H, Itoh S, Asano T. The role of active smooth-muscle contraction in the occurrence of chronic vasospasm in the canine two-hemorrhage model. J Neurosurg. 1994;80:276-282.
12. Harder DR, Dernach P, Waters A. Possible cellular mechanism for cerebral vasospasm after experimental subarachnoid hemorrhage in the dog. J Clin Invest. 1987;80:875-880.
13. Yamada K, Ohta T, Schimizu K, Yasuda A. Effect of nicorandil on cerebral vasospasm. Jpn J Clin Pharmacol Ther. 1989;20:381-390.
14. Matsui T, Nagafuji T, Uchida H, Miyauchi T, Asano T. The effect of nicorandil on chronic cerebral vasospasm. In: Findlay JM, ed. Cerebral Vasospasm. Amsterdam, Netherlands: Elsevier Science Publishing Co; 1993:357-360.
15. + channel opening and guanylate cyclase stimulation to its vasorelaxant effects on various endothelin-1-contracted arterial preparations: comparison to aprikalim (RP 52891) and nitroglycerin. J Pharmacol Exp Ther. 1991;259:526-534.
16. + channel-dependent and cyclic GMP-dependent components in a single vascular preparation. J Cardiovasc Pharmacol. 1991;17: 903-912.
17. Kreye VA, Lenz T, Pfrunder D, Theiss U. Pharmacological characterization of nicorandil by 86Rb efflux and isometric vasorelaxation studies in vascular smooth muscle. J Cardiovasc Pharmacol. 1992;20(suppl 3):S8-S12.
18. Kukovetz WR, Holzmann S, Poch G. Molecular mechanism of action of nicorandil. J Cardiovasc Pharmacol. 1992;20(suppl 3):S1-S7.
19. m. Stroke. 1985;16:990-997.
20. Wellum GR, Peterson JW, Zervas NT. The relevance of in vitro smooth muscle experiments to cerebral vasospasm. Stroke. 1985;16: 573-581.
21. Peterson JW, Bun T, Zervas NT. Plasma-borne vasoactivity and modulation by the endothelium as determinants of cerebrovascular tone: possible role during cerebral vasospasm. In: Raichle ME, Powers WI, eds. Cerebrovascular Disease. New York, NY: Raven Press Publishers; 1987:187-199.
22. Zuccarello M, Bonasso CL, Sperelakis N, Rapoport RM. Role of membrane potential in vasospasm after subarachnoid hemorrhage. In: Findlay JM, ed. Cerebral Vasospasm. Amsterdam, Netherlands: Elsevier Science Publishing Co; 1993:229-233.
23. + channels in vasospasm after subarachnoid hemorrhage. Stroke. 1993;24:168. Abstract.
24. + channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide. J Pharmacol Exp Ther. 1989;250:261-27l.
25. + channels? Trends Pharmacol Sci. 1993;14:332-337.
26. Matsui T, Takuwa Y, Joshita H, Yamashita K, Asano T. Possible role of protein kinase C-dependent smooth muscle contraction in the pathogenesis of chronic cerebral vasospasm. J Cereb Blood Flow Metab. 1991;11:143-149.
27. Yakubu MA, Shibata M, Leffler CW. Subarachnoid hematoma attenuates vasodilation and potentiates vasoconstriction induced by vasoactive agents in newborn pigs. Pediatr Res. 1994;36:589-594.
28. Faraci FM, Heistad DD. Role of ATP-sensitive potassium channels in the basilar artery. Am J Physiol. 1993;264:H8-H13.
29. + channels in CGRP-induced dilatation of basilar artery in vivo. Am J Physiol. 1995;265:H581-H585.
30. Mayhan WG, Faraci FM. Responses of cerebral arterioles in diabetic rats to activation of ATP-sensitive potassium channels. Am J Physiol. 1993;265:H152-H157.
31. + channels mediate dilatation of cerebral arterioles during hypoxia. Circ Res. 1994;74:1005-1008.
32. Plane F, Garland CJ. Differential effects of acetylcholine, nitric oxide and levcromakalim on smooth muscle membrane potential and tone in the rabbit basilar artery. Br J Pharmacol. 1993;110: 651-656.
33. B receptors in subarachnoid hemorrhage-induced cerebral vasospasm. Eur J Pharmacol. 1994;259:R1-R2.
34. Seifert V, Loffler BM, Zimmermann M, Roux S, Stolke D. Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage: correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. J Neurosurg. 1995; 82:55-62.
35. + channels and depolarizes smooth muscle cells of porcine coronary artery. Circ Res. 1992;70: 612-616.
36. + channel in smooth muscle cells of porcine coronary artery. Eur J Pharmacol. 1991;194:31-36.
37. + channel by angiotensin II and endothelin-1. Biochem Pharmacol. 1995;49: 1051-1056.